Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysisSunil Taneja, Harbir Singh Kohli, Ajay Duseja et al.|Liver International|2020Cited by 27
Nurturing Global Leadership, Advocacy, Research, and Collegiality: The Unique Experience of The International Society of Nephrology Emerging Leaders ProgramSabine Karam, Rahul Chanchlani, Elliot Koranteng Tannor et al.|Kidney International Reports|2023Cited by 1
Access to and Barriers to Access for Essential Medicines in Nephrology and Related Non-Communicable Diseases: A Scoping Review ProtocolMichelle Wong, Vivekanand Jha, Viviane Cálice-Silva et al.|Research Square|2021Cited by 0
POS-327 BARRIERS TO ACCESSING ESSENTIAL MEDICINES FOR KIDNEY DISEASE: AN INTERNATIONAL SURVEYAnna Francis, Vivekanand Jha, T. Chen et al.|Kidney International Reports|2022Cited by 0
WCN24-758 RECOGNITION OF LOCAL INVESTIGATORS IN AUTHORSHIP OF COLLABORATIVE KIDNEY RESEARCH CONDUCTED IN LOW- AND LOWERMIDDLE INCOME COUNTRIESEranga Wijewickrama, Robert Kalyesubula, Rahul Chanchlani et al.|Kidney International Reports|2024Cited by 0